Sign up to save your podcasts
Or
Share FDA Approved Therapy for SOD1 Associated ALS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA Approved Therapy for SOD1 Associated ALS
Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.
Read the related article on the FDA website.
Disclosures can be found at Neurology.org
View all episodes
By American Academy of Neurology
4.7
279279 ratings
Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.
Read the related article on the FDA website.
Disclosures can be found at Neurology.org
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
134 Listeners
NEJM This Week
318 Listeners
Practical Neurology Podcast
48 Listeners
JAMA Clinical Reviews
498 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,105 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
517 Listeners
Neurology Minute
131 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
367 Listeners
Continuum Audio
79 Listeners